Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Diamond

Showing results (341-350 of 344) with videos related to

Pageof 35
Sort By:
You have reached the last page of results.This site can display upto 344 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2020
Preclinical and Dose-Finding Phase I Trial Results of Combined Treatment with a TORC1/2 Inhibitor (TAK-228) and Aurora A Kinase Inhibitor (Alisertib) in Solid TumorsS Lindsey Davis, Anastasia A Ionkina, Stacey M Bagby, et al.
Science Translational Medicine|May 1, 2024
Multimodal MRI reveals brainstem connections that sustain wakefulness in human consciousnessBrian L Edlow, Mark Olchanyi, Holly J Freeman, et al.
NPJ Breast Cancer|May 20, 2023
Phase II trial of fulvestrant plus enzalutamide in ER+/HER2- advanced breast cancerAnthony D Elias, Nicole S Spoelstra, Alyse W Staley, et al.
Frontiers in Immunology|April 15, 2021
Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell PhenotypesJuan A Marín-Jiménez, Anna Capasso, Matthew S Lewis, et al.
Pageof 35

Showing results (341-350 of 344) with videos related to

Sort By:
Pageof 35
You have reached the last page of results.This site can display upto 344 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2020
Preclinical and Dose-Finding Phase I Trial Results of Combined Treatment with a TORC1/2 Inhibitor (TAK-228) and Aurora A Kinase Inhibitor (Alisertib) in Solid TumorsS Lindsey Davis, Anastasia A Ionkina, Stacey M Bagby, et al.
Science Translational Medicine|May 1, 2024
Multimodal MRI reveals brainstem connections that sustain wakefulness in human consciousnessBrian L Edlow, Mark Olchanyi, Holly J Freeman, et al.
NPJ Breast Cancer|May 20, 2023
Phase II trial of fulvestrant plus enzalutamide in ER+/HER2- advanced breast cancerAnthony D Elias, Nicole S Spoelstra, Alyse W Staley, et al.
Frontiers in Immunology|April 15, 2021
Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell PhenotypesJuan A Marín-Jiménez, Anna Capasso, Matthew S Lewis, et al.
Pageof 35